FLT3 gene mutations occur with a frequency of about 25–30% in AML [10,11], the vast majority as ITDs with varying IS (FLT3-ITD) or as tyrosine kinase domain (TKD) point mutations in about 5% (FLT3-TKD). The gene discussed is FLT3; the disease is acute myeloid leukemia.